Development of the CpG Adjuvant 1018: A Case Study.

about

An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al2O3 nanoparticles.

P2860

Q39174792-F89158CE-64FD-409C-BE23-90DD303FBB01 Q52620810-CC8CB897-9FCD-48D8-ADD9-BE7D6C3DB06C Q55183971-87D2562F-A7FF-41C4-AE64-7FB075ABF816

P2860

Development of the CpG Adjuvant 1018: A Case Study.

Item

http://www.wikidata.org/entity/Q40549653

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Development of the CpG Adjuvant 1018: A Case Study.

@en

type

Item

label

Development of the CpG Adjuvant 1018: A Case Study.

@en

prefLabel

Development of the CpG Adjuvant 1018: A Case Study.

@en

P1476

Development of the CpG Adjuvant 1018: A Case Study.

@en

P2093

John D Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogen recognition and inflammatory signaling in innate immune defenses

Vaccination greatly reduces disease, disability, death and inequity worldwide

Recent advances of vaccine adjuvants for infectious diseases

Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands

Hepatitis B virus: where do we stand and what is the next step for eradication?

Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.

CpG motifs in bacterial DNA trigger direct B-cell activation.

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Hepatitis B vaccines.

A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.

P304

15-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-6445-1_2

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1494

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27718183

http://www.w3.org/2001/XMLSchema#string

Development of the CpG Adjuvant 1018: A Case Study.

about

P2860

P2860

Development of the CpG Adjuvant 1018: A Case Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698